Comparison Chart DiaMedica Therapeutics Inc.

Stocks

DMAC

CA25253X2077

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 09:23:41 28/10/2026 pm IST			5-day change	1st Jan Change
9.720 ^USD	+11.85%		+12.31%	+22.61%

22/10	DiaMedica Therapeutics Reaches Patient Enrollment Milestone for Phase 2/3 Trial of DM199 in Acute Ischemic Stroke	MT
22/10	DiaMedica Therapeutics Inc. Announces Enrollment Of 200th Patient In Its Pivotal Phase 2/3 ReMEDy2 Trial Of DM199 In Acute Ischemic Stroke	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	DIAMEDICA THERAPEUTICS INC.	Bio Therapeutic Drugs	+12.31%	+12.31%	+22.61%	+43.74%	+144.00%	47Cr	-	-	-